| Title | Cancer Epidemiology Biomarkers and Prevention |
| Abbreviation | Cancer Epidemiol. Biomark. Prev. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Epidemiology (Q1); Medicine (miscellaneous) (Q1); Oncology (Q1) |
| h-index | 219 |
| Overall Rank/Ranking | 1531 |
| SCImago Journal Rank (SJR) | 1.939 |
| Impact Score | 2.91 |
| Publisher | American Association for Cancer Research Inc. |
| Country | United States |
| ISSN | 10559965, 15387755 |
| Best Quartile | Q1 |
| Coverage History | 1983, 1986, 1991-2025 |
Cancer Epidemiology, Biomarkers & Prevention publishes original, peer-reviewed research on cancer causation, mechanisms of carcinogenesis, prevention, and survivorship. Topics include descriptive, analytical, biochemical, and molecular epidemiology; the use of biomarkers to study the neoplastic and preneoplastic processes in humans; chemoprevention and other types of prevention trials; and the role of behavioral factors in cancer etiology and prevention. All submissions undergo peer review.
Cancer Epidemiology Biomarkers and Prevention is a journal covering the technologies/fields/categories related to Epidemiology (Q1); Medicine (miscellaneous) (Q1); Oncology (Q1). It is published by American Association for Cancer Research Inc.. The overall rank of Cancer Epidemiology Biomarkers and Prevention is 1531. According to SCImago Journal Rank (SJR), this journal is ranked 1.939. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 219. The best quartile for this journal is Q1.
The ISSN of Cancer Epidemiology Biomarkers and Prevention journal is 10559965, 15387755. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cancer Epidemiology Biomarkers and Prevention is cited by a total of 2783 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Cancer Epidemiology Biomarkers and Prevention is 2.91, which is computed in 2025 as per its definition. Cancer Epidemiology Biomarkers and Prevention IF is decreased by a factor of 0.17 and approximate percentage change is -5.52% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Cancer Epidemiology Biomarkers and Prevention is 2.91. If the same downward trend persists, Impact IF may fall in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.91 |
| 2023 | 3.08 |
| 2022 | 3.39 |
| 2021 | 3.61 |
| 2020 | 3.66 |
| 2019 | 4.05 |
| 2018 | 4.77 |
| 2017 | 4.51 |
| 2016 | 4.20 |
| 2015 | 3.96 |
| 2014 | 4.51 |
Cancer Epidemiology Biomarkers and Prevention has an h-index of 219. It means 219 articles of this journal have more than 219 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Cancer Epidemiology Biomarkers and Prevention is 10559965, 15387755. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Cancer Epidemiology Biomarkers and Prevention is 1531. According to SCImago Journal Rank (SJR), this journal is ranked 1.939. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.939 |
| 2023 | 1.688 |
| 2022 | 1.923 |
| 2021 | 1.274 |
| 2020 | 2.234 |
| 2019 | 2.857 |
| 2018 | 3.311 |
| 2017 | 2.582 |
| 2016 | 2.610 |
| 2015 | 2.556 |
| 2014 | 2.851 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1531 |
| 2023 | 1830 |
| 2022 | 1410 |
| 2021 | 2776 |
| 2020 | 1101 |
| 2019 | 725 |
| 2018 | 551 |
| 2017 | 868 |
| 2016 | 846 |
| 2015 | 898 |
| 2014 | 733 |
Cancer Epidemiology Biomarkers and Prevention is published by American Association for Cancer Research Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 1983, 1986, 1991-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Cancer Epidemiology Biomarkers and Prevention is Cancer Epidemiol. Biomark. Prev.. This abbreviation ('Cancer Epidemiol. Biomark. Prev.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Epidemiology (Q1); Medicine (miscellaneous) (Q1); Oncology (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Cancer Epidemiology Biomarkers and Prevention latest impact IF is 2.91. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 4.77 (2018) and 2.91 (2024), respectively, in the last 11 years. Moreover, its average IS is 3.88 in the previous 11 years.
The Cancer Epidemiology Biomarkers and Prevention has an SJR (SCImago Journal Rank) of 1.939, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 3.311 in 2018 and the lowest being 1.274 in 2021. Furthermore, the average SJR of the Cancer Epidemiology Biomarkers and Prevention over the previous 11-year period stands at 3.88.
The latest h-index of the Cancer Epidemiology Biomarkers and Prevention is 219.
The Cancer Epidemiology Biomarkers and Prevention is published by the American Association for Cancer Research Inc., with its country of publication being the United States.
The Cancer Epidemiology Biomarkers and Prevention is currently ranked 1531 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 551 in 2018 and its lowest position of 2776 in 2021.
The standard ISO4 abbreviation for the Cancer Epidemiology Biomarkers and Prevention is Cancer Epidemiol. Biomark. Prev..
Cancer Epidemiology Biomarkers and Prevention is classified as a journal that the American Association for Cancer Research Inc. publishes.
The Cancer Epidemiology Biomarkers and Prevention encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Cancer Epidemiology Biomarkers and Prevention is assigned the following International Standard Serial Numbers (ISSN): 10559965, 15387755.
The best quartile for the Cancer Epidemiology Biomarkers and Prevention is Q1 (2024).
The Cancer Epidemiology Biomarkers and Prevention coverage history can be summarized as follows: 1983, 1986, 1991-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Academic Ethics | journal | 8704 | Springer Netherlands | 34 | 4.04 |
| Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division | conference and proceedings | 17477 | 16 | 0.00 | |
| Applied Ecology and Environmental Research | journal | 19122 | Corvinus University of Budapest | 48 | 0.84 |
| Qualitative Research | journal | 1300 | SAGE Publications Ltd | 101 | 6.77 |
| CESifo Economic Studies | journal | 17776 | Oxford University Press | 36 | 0.89 |
| Libyan Studies | journal | 21508 | Cambridge University Press | 10 | 0.14 |
| Sapporo Medical Journal | journal | 29756 | Sapporo Medical University | 3 | 0.00 |
| Oral Radiology | journal | 9860 | Springer Japan | 28 | 2.17 |
| Journal of Tropical Agriculture | journal | 25098 | Kerala Agricultural University | 21 | 0.26 |
| Journal of Tissue Engineering and Regenerative Medicine | journal | 8612 | John Wiley and Sons Ltd | 95 | 3.01 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.91 |
| 2023 | 3.08 |
| 2022 | 3.39 |
| 2021 | 3.61 |
| 2020 | 3.66 |
| 2019 | 4.05 |
| 2018 | 4.77 |
| 2017 | 4.51 |
| 2016 | 4.20 |
| 2015 | 3.96 |
| 2014 | 4.51 |
